SIRPA and neoplasm: Notably, PD-1 NVs, SIRPα NVs, and PD-1/SIRPα NVs significantly inhibited tumor growth by day 15, with hybrid nanovesicles exhibiting the most robust tumor suppression effect (Figure 4A).